Gene delivery methods and genome editing of human pluripotent stem cells

• Published in: Reports of practical oncology and radiotherapy Vol. 24; no. 2; pp. 180 - 187
• Main Authors: Czerwińska, Patrycja, Mazurek, Sylwia, Kołodziejczak, Iga, Wiznerowicz, Maciej
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.03.2019; Elsevier
• Subjects: CRISPR/Cas9; Genome editing; Induced pluripotent stem cells; Review; Stem cells; TALEN; ZFN; Genome editing; ZFN; CRISPR/Cas9; Induced pluripotent stem cells; TALEN; Stem cells
• ISSN: 1507-1367; 2083-4640
• DOI: 10.1016/j.rpor.2019.01.007

Induced pluripotent stem cells derived from normal somatic cells could be utilized to study tumorigenesis through overexpression of specific oncogenes, downregulation of tumor suppressors and dysregulation of other factors thought to promote tumorigenesis. Therefore, effective approaches that provide direct modifications of induced pluripotent stem cell genome are extremely needed. Emerging strategies are expected to provide the ability to more effectively introduce diverse genetic alterations, from as small as single-nucleotide modifications to whole gene amplification or deletion, all with a high degree of target specificity. To date, several techniques have been applied in stem cell studies to directly edit cell genome (ZFNs, TALENs or CRISPR/Cas9). In this review, we summarize specific gene delivery strategies that were applied to stem cell studies together with genome editing techniques, which enable a direct modification of endogenous DNA sequences in the context of cancer studies.